Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOLEUCOVORIN Cause Hepatic function abnormal? 15 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Hepatic function abnormal have been filed in association with LEVOLEUCOVORIN (Levoleucovorin). This represents 0.5% of all adverse event reports for LEVOLEUCOVORIN.

15
Reports of Hepatic function abnormal with LEVOLEUCOVORIN
0.5%
of all LEVOLEUCOVORIN reports
1
Deaths
11
Hospitalizations

How Dangerous Is Hepatic function abnormal From LEVOLEUCOVORIN?

Of the 15 reports, 1 (6.7%) resulted in death, 11 (73.3%) required hospitalization, and 3 (20.0%) were considered life-threatening.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOLEUCOVORIN. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOLEUCOVORIN Cause?

Diarrhoea (302) Nausea (274) Neutropenia (246) Decreased appetite (223) Neuropathy peripheral (178) Neutrophil count decreased (176) Pyrexia (175) Vomiting (167) Febrile neutropenia (130) Off label use (125)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Which LEVOLEUCOVORIN Alternatives Have Lower Hepatic function abnormal Risk?

LEVOLEUCOVORIN vs LEVOMEPROMAZINE LEVOLEUCOVORIN vs LEVOMETHADONE LEVOLEUCOVORIN vs LEVOMILNACIPRAN LEVOLEUCOVORIN vs LEVONORGESTREL LEVOLEUCOVORIN vs LEVORPHANOL

Related Pages

LEVOLEUCOVORIN Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal LEVOLEUCOVORIN Demographics